Mirati Therapeutics Cash and Cash Equivalents 2011-2026 | MRTX

Annual Cash and Cash Equivalents Mirati Therapeutics

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
235 M	413 M	886 M	46.5 M	32.7 M	108 M	22.4 M	49.5 M	6.59 M	14.2 M	18.4 M	9.88 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
886 M	6.59 M	153 M

Quarterly Cash and Cash Equivalents Mirati Therapeutics

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
259 M	130 M	242 M	235 M	299 M	266 M	305 M	413 M	243 M	281 M	330 M	886 M	886 M	886 M	886 M	46.5 M	46.5 M	46.5 M	46.5 M	32.7 M	32.7 M	32.7 M	32.7 M	108 M	108 M	108 M	108 M	22.4 M	22.4 M	22.4 M	22.4 M	49.5 M	49.5 M	49.5 M	49.5 M	6.59 M	6.59 M	6.59 M	6.59 M	14.2 M	14.2 M	14.2 M	14.2 M	18.4 M	18.4 M	18.4 M	-	9.88 M	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
886 M	6.59 M	164 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	1.91 M	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	261 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	3.06 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	4.76 B	-	-	$ 866 M	China
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	81.8 M	-	2.54 %	$ 160 B	France
AstraZeneca PLC AZN	5.71 B	-	-	$ 96.9 B	Britain
Athira Pharma ATHA	69.3 M	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	54 M	-	0.74 %	$ 768 M	Israel
Galera Therapeutics GRTX	6.38 M	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	8.53 M	-	-18.52 %	$ 27.3 M	Britain
Checkmate Pharmaceuticals CMPI	50.7 M	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	12.4 M	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	86.5 M	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	76.3 M	-	-	$ 344 M	USA
IMV IMV	21.2 M	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	340 M	-	-	$ 3.67 B	USA
BioNTech SE BNTX	7.68 B	$ 91.4	1.15 %	$ 22.1 B	Germany
Autolus Therapeutics plc AUTL	104 M	$ 1.66	2.21 %	$ 442 M	Britain
Ayala Pharmaceuticals AYLA	2.41 M	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	3.5 M	-	-4.36 %	$ 27 M	USA
Compugen Ltd. CGEN	90.6 M	$ 2.65	-2.22 %	$ 248 M	Israel
Anika Therapeutics ANIK	57.5 M	$ 15.09	-0.33 %	$ 216 M	USA
Advaxis ADXS	4.88 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	7.31 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	85.7 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	811 M	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	46.4 M	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	5.53 M	$ 3.4	2.41 %	$ 5.6 M	Israel
AIkido Pharma AIKI	34 M	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	935 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	56.2 M	-	-39.0 %	$ 4.57 M	USA
Coherus BioSciences CHRS	88.9 M	$ 1.6	5.63 %	$ 187 M	USA
Akouos AKUS	122 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	248 M	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	98.1 M	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	17.8 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	42.9 M	$ 20.95	2.34 %	$ 2.67 B	USA
Allena Pharmaceuticals ALNA	30 M	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	4.09 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	61.1 M	-	-	$ 10.1 M	USA
Alpine Immune Sciences ALPN	13.4 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	3.22 M	-	10.36 %	$ 9.8 M	USA
Applied Therapeutics APLT	49.9 M	-	-	$ 8.42 M	USA
Aravive ARAV	53.7 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	4.88 M	-	17.91 %	$ 11.1 M	USA